Company signals
Tate & Lyle
2 signals in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: This lands while the Talent Market Index reads 112.9 (Hot) — up 11.4 versus the prior month — and Americas signal share is rising (+2.5pts).
Tate & Lyle: 2 signals in the last 90 days; 0.1% of MitchelLake's Americas signal flow.
Signals at Tate & Lyle
Ma Activity
EMEABritish food ingredients company Tate & Lyle is subject of takeover bid from US-based Ingredion worth £2.74 billion. Share price surged 55% on announcement. Company facing declining revenue/profit, weak US bakery demand, rising costs.
Leadership read: Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in the sector.
curated · 2026-05-14 · context →
Ma Activity
AmericasTate & Lyle received a £2.7bn takeover bid from US-based Ingredion at 615p per share. Board is in active discussions with the bidder. Deadline for firm offer is June 11, 2026.
Leadership read: Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in the sector.
curated · 2026-05-14 · context →
More signals across Americas
Ma Activity · Americas
Commerce →Commerce (Kansas City bank) acquiring boutique middle-market investment bank Nolan & Associates (St. Louis-based) to expand investment banking advisory capabilities.
Ma Activity · Americas
Biogen →Biogen acquired Apellis Pharmaceuticals for $5.6B and subsequently paused or canceled the majority of research programs that came with the acquisition, laying off a small number of employees from Apellis.
Ma Activity · Americas
Cineverse →Cineverse completed transformative acquisitions of IndiCue and Giant Worldwide, evolving into an AI-driven, fully integrated entertainment technology company and studio. The acquisitions contributed $11.6 million of revenue in their first partial quarter.
Ma Activity · Americas
Haleon →Haleon is among multiple bidders competing to acquire Thorne, a supplements maker, signaling interest in the nutritional health market segment.
Ma Activity · Americas
Agilent Technologies →Agilent Technologies completed the acquisition of Biocare Medical from Excellere Partners and GHO Capital Partners. Biocare is a global leader in immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) solutions.
Ma Activity · Americas
GMS →GMS acquired the assets of Central Materials, a distributor of stucco, EIFS, stone, masonry, and related cladding products, to expand its South Texas cladding products presence.
Intelligence powered by Autonodal ↗